Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion - Wikidata - awgldk - TriplyDB

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

http://www.wikidata.org/entity/Q36945852

about

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets Environmental risk factors for type 1 diabetes Type 1 diabetes mellitus.Pathogenic CD4+ T cells in patients with asthma.Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.Progress and challenges for treating Type 1 diabetes.Single-cell analysis of glandular T cell receptors in Sjögren's syndrome.B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes.Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.Efficient Presentation of Multiple Endogenous Epitopes to Both CD4+ and CD8+ Diabetogenic T Cells for Tolerance In Vivo Enrichment of Diabetogenic T Cells.Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes.Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).Chromogranin A as biomarker in diabetes.Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.Restoring Regulatory T Cells in Type 1 Diabetes.Endoplasmic reticulum stress in beta cells and autoimmune diabetes.Immune targets and neoantigens for cancer immunotherapy and precision medicine.The multiple pathways to autoimmunity.Understanding type 1 diabetes through proteomics.Memory T Cells in Type 1 Diabetes: the Devil is in the Detail.Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.Rapid identification and expression of human TCRs in retrogenic mice.Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.The Four-Way Stop Sign: Viruses, 12-Lipoxygenase, Islets, and Natural Killer Cells in Type 1 Diabetes Progression The SysteMHC Atlas project.Glucose Driven Changes in Beta Cell Identity Are Important for Function and Possibly Autoimmune Vulnerability during the Progression of Type 1 Diabetes.Is Tolerance Broken in Autoimmunity?Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.T Cell Receptor Profiling in Type 1 Diabetes.Antigen-Specific Immune Modulation Targets mTORC1 Function To Drive Chemokine Receptor-Mediated T Cell Tolerance.Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.Stacking the Deck: Studies of Patients with Multiple Autoimmune Diseases Propelled Our Understanding of Type 1 Diabetes as an Autoimmune Disease.Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes.C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes.

P2860

Q26751244-84DF43B1-49EB-49F9-9B8F-98A63DC76422 Q28276366-C4AAAFD1-4896-4C29-B156-C745F2B2DCE9 Q30235021-8B29CB1F-1618-440C-8D32-7F7A8995C225 Q30252507-BDDFDF7E-FB7A-4104-887C-759507419650 Q33584702-FFF9C83C-593B-4D3B-B873-BA27668269EC Q33894929-BD049EE6-BC41-4AC3-9CE4-85DDE6962B36 Q36995389-E72F5C3D-A1EF-44D5-9109-820029DB9AF7 Q37041516-980C2752-714C-455E-BBB8-B678B05DF649 Q37449736-950A6DF5-BC26-4E1F-A0DA-239D408894AE Q37478584-9848E7E8-D5A7-47D1-B9F6-C1BE67D60339 Q37698306-F30A20C8-F353-4211-A31E-4F2D89146C70 Q37717905-30061152-2AC5-491D-BCD3-7ED3A282623F Q38708157-380399F7-683C-46B8-A58A-B05D14581C21 Q38771022-F86D6D92-A928-4B4C-9724-E93FB4ED5105 Q38857800-7FBB7D6A-BA4F-424F-8B29-0A2D417926B5 Q38950132-6A179777-5A07-46FD-8418-7B19C335CF16 Q38950436-0869B0A6-F6CC-4310-956B-507748B85516 Q38963375-85692EA0-34A7-4FFD-BA97-4875A3F0A074 Q38975660-3A99ECEB-9A7D-48C7-8076-EB414F5EFF2B Q39057617-1C50F2E6-F368-4B83-8262-8A95AAD0DE60 Q39386100-F18F03D9-D38E-4BFD-9D0B-D96BA53F9DB2 Q39398068-FCBED091-5F5D-40DB-A69F-0291FA91EBAF Q39410575-1DC594A4-CF5A-4E50-9160-33285E09ABFA Q39665315-47B61152-768A-4FFD-A497-580AF579F4DF Q40317955-3F7C27B3-2E73-4FD0-8145-40B3CFDDEC76 Q40596750-C14D58B8-CE01-4FC8-A59D-88C6C96B990B Q40998700-28254393-7EFA-4009-A479-5C858F931AAB Q41921221-E75951A8-5731-4BAF-A47D-1C593FC2BC90 Q41990341-EA9E9E9D-E609-400F-A060-A2261F3C2B56 Q42105034-20CEBA7C-A1ED-4560-AA9B-E8FF49D95790 Q42348082-C8923FA0-2C3B-41D7-B51F-662B0D2A7021 Q42369799-AC2FCD97-291E-4D74-9116-24A2871E1E95 Q42374922-5B1D778A-3AB9-4423-9E9E-B9B60A52EA71 Q42578734-22EF92D8-21B6-475A-9FD8-E20EE516479C Q45048293-1EF04917-65D9-4DCB-B575-BCBFF1F6E0CD Q45070795-712D1E41-133B-44C6-9872-1FB7E8512643 Q45818945-DCBAE623-F59B-43AD-8779-64C4D055606D Q46237108-198A9BE8-B5B9-4682-87CF-E8368E67E8FA Q46360981-6ED39E9E-2B2D-42D5-8356-EA627575A96A Q46453590-B8064EE6-1826-444B-9CE4-153430E7A601

P2860

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

http://www.wikidata.org/entity/Q36945852

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

@en

type

label

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

@en

prefLabel

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

@en

P1433

Q36945852-8F24B135-0782-4B1B-BD09-59C9DDF32816

P1476

Q36945852-86704E59-2B35-4CED-94E8-24BE56593185

P2093

Q36945852-2D1652D5-4BEA-44DB-9F42-E33BAC92B08C

Q36945852-3EB974F6-295C-49FA-A6DD-03C2A10DF29E

Q36945852-57AACCD5-21CF-4E7E-8FE3-41C897A1523E

Q36945852-9475C3A4-6CBF-465A-8997-F925D0EBD3DD

Q36945852-A9CFDE71-14B4-49D9-91AE-9D08AFB2C79B

Q36945852-AECE29C5-24B4-48B1-9A9D-B7C7BB512F48

Q36945852-B6F8D63A-7499-4460-8ED9-849F6DE35B08

Q36945852-C5029FE6-8647-4CDE-875C-50E263D86633

Q36945852-CCE8A4B7-0A85-4669-B1BE-79633F75EBFA

Q36945852-D13BC55F-D6D4-41F8-AD20-07386357FE80

P2860

Q36945852-23E2F2B3-A9DA-4C78-BCCC-8F115F47E88B

Q36945852-260009FA-4F2B-45F0-B42F-BF681409855D

Q36945852-353B8835-7A13-4092-93BD-1CD88AB54915

Q36945852-38E10B6A-3748-4A17-B69E-6CF594EC76A5

Q36945852-465DE35B-9159-4298-83A6-1E5B0F2EE53B

Q36945852-49EB0045-72C5-47D6-9A4C-933D16F3BA04

Q36945852-57236F9E-1B05-47DA-9C52-81DFADE34B36

Q36945852-59E7F092-F69E-4C17-A997-DFC30388FE38

Q36945852-627BD167-B8F2-4F72-9DDB-7C8BE1D6BDE9

Q36945852-6F0F5D0C-10DF-4DDA-BC1D-CBC51772D21F

P304

Q36945852-6D037250-D08F-44B8-A53D-7002CBB12C4B

P31

Q36945852-144A62A1-823D-419D-8CB9-85368591540B

P356

Q36945852-7F065F5B-09CC-4175-A23C-2256E512F91F

P407

Q36945852-E29E81A0-173B-4384-8DE5-49D3F179FBF2

P433

Q36945852-779B7ED7-BD14-47AE-85FB-CC2B65CCC3B5

P478

Q36945852-65102C6C-99AE-4A90-BF07-DEF234410DC1

P50

Q36945852-69F388DA-FF59-4485-93B9-33DEC96D9C43

Q36945852-F929DCE4-6DCA-422E-B000-BC951C34C43F

P577

Q36945852-4E898792-DEA0-4D4F-9B10-E82E3FB9A42C

P698

Q36945852-9FB61287-F05C-4463-A4DC-5074F847F95E

P921

Q36945852-93DACF48-9086-4734-A782-355A5E79F708

P932

Q36945852-8F0A8443-39F0-4BA1-80C2-4228AAE7708A

P356

SCIENCE.AAD2791

P1433

P1476

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

@en

P2093

Alvin C Powers

http://www.w3.org/2001/XMLSchema#string

Brenda Bradley

http://www.w3.org/2001/XMLSchema#string

Colleen M Elso

http://www.w3.org/2001/XMLSchema#string

David M Harlan

http://www.w3.org/2001/XMLSchema#string

Gene Barbour

http://www.w3.org/2001/XMLSchema#string

Kathryn Haskins

http://www.w3.org/2001/XMLSchema#string

Megan DeNicola

http://www.w3.org/2001/XMLSchema#string

Michael Armstrong

http://www.w3.org/2001/XMLSchema#string

Nichole Reisdorph

http://www.w3.org/2001/XMLSchema#string

Nitesh Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Chromogranin A is an autoantigen in type 1 diabetes

Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro.

Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse.

Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells

The NOD mouse model of type 1 diabetes: as good as it gets?

MHC class II tetramers

An antigenic peptide produced by peptide splicing in the proteasome.

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

An antigen produced by splicing of noncontiguous peptides in the reverse order.

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

P304

711-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAD2791

http://www.w3.org/2001/XMLSchema#string

P407

P433

6274

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P50

Rocky Lee Baker

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26912858

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4884646

http://www.w3.org/2001/XMLSchema#string